PREDICTION OF OUTCOMES AFTER STROKE: A SYSTEMATIC REVIEW


Cite item

Full Text

Abstract

In the contemporary world one of the leading causes of death and disability of the population belongs to the stroke. The average frequency of death within the first 30 days after stroke varies from 17 % to 34 %. During the first year about 50 % of patients die. Only 20 % of stroke survivors recover completely, while 80 % of these patients are permanently disabled. Along with the issues of stroke's prevention, treatment and its rehabilitation, it is a relevant aspect to predict the outcome of the patient in the post-stroke condition. It is known that the timely prediction of the cerebral stroke's outcome allows to avoid patient's death and to reduce the neurological deficit in case of correct appointment. Predictive models and scales are the simplest and most accessible instrument for estimating the patient's condition and predicting the outcome after stroke. Despite a considerable quantity of studies in this area the problem of forecasting the stroke's outcome is still relevant. Over the past 10 years the predictive value of some clinical scales has been further investigated, new information about biomarkers has been obtained, whose appearance in the blood correlates with the outcome of stroke, and which could potentially be used in predictive models. The information is not always available for physicians and researchers because of the presence of fragmentation and a language barrier. So the aim of this systematic review was analyzing and combining the available information of the methods predicting the stroke's outcome in the past 10 This review article presents an analysis of methods predicting the outcome in patients after stroke. The study included full-text publications in the English language for the last 10 years, describing the scales or models predicting the post-stroke's outcome in patient. We studied 668 sources in databases MEDLINE, SCOPUS, describing the clinical scales or prediction models that use serum biomarkers as predictors. After screening, 35 articles were selected and included in the analysis.

About the authors

I A Kadyrova

Karaganda State Medical University

Karaganda, Kazakhstan

F A Mindubaeva

Karaganda State Medical University

Karaganda, Kazakhstan

A M Grjibovski

Northern State Medical University, Norwegian Institute of Public Health, International Kazakh-Turkish University

Email: Andrej.Grjibovski@gmail.com
доктор медицины, магистр международного общественного здравоохранения, старший советник Национального института общественного здравоохранения, г. Осло, Норвегия; директор Архангельской международной школы общественного здоровья, г. Архангельск, Россия; профессор Международного казахско-турецкого университета им. Х. А. Ясави, г. Туркестан, Казахстан Arkhangelsk, Russia; Oslo, Norway; Turkestan, Kazakhstan

References

  1. Гусев Е. И. Проблема инсульта в России // Журнал неврологии и психиатрии им. С. С. Корсакова (Инсульт приложение к журналу). 2003. № 9. С. 3-7.
  2. Гусев Е. И., Скворцова В. И. Ишемия головного мозга. М. : Медицина, 2001. С. 13.
  3. Денисова Е. В. Актуальные вопросы эпидемиологии сосудистых заболеваний головного мозга в мире (обзор литературы) // Вестник общественного здоровья и здравоохранения. 2011. № 3. URL: http://fesmu.ru/ voz/20113/201131 1.aspx (дата обращения: 15.04.2015)
  4. Alberts M. J. Ischemic stroke // Cerebrovascular Diseases. 2002. Vol. 13 (suppl. 1). P. 12-16.
  5. Arenillas J. F., Alvarez-Sabín J., Molina C. A., Chacon P., Fernández-Cadenas I., Ribó M., Delgado P., Rubiera M., Penalba A., Rovira A., Montaner J. Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis // Stroke. 2008. N 39 (5). Р 1456-1463.
  6. Ay H., Arsava E. M., Gungor L., Greer D., Singhal A. B., Furie K. L., Koroshetz W. J., Sorensen A. G. Admission international normalized ratio and acute infarct volume in ischemic stroke // Ann. Neurol. 2008. N 64 (5). Р 499-506.
  7. Barber M., Langhorne P., Rumley A., Lowe G. D., Stott D. J. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression // Stroke. 2004. N 35 (6). P. 1421-1425.
  8. Birkner M. D., Kalantri S., Solao V., Badam P., Joshi R., Goel A., Pai M., Hubbard A. E. Creating diagnostic scores using data-adaptive regression. An application to prediction of 30-day mortality among stroke victims in a rural hospital in India // Ther Clin Risk Manag. 2007. N 3 (3). Р. 475-484.
  9. Bowler J. V., Hachinski V. Cognitive performance after first ever stroke related to progression of vascular brain damage: a 2 year follow up CT scan study // J. Neurol. Neurosurg. Psychiatry. 2005. N 76 (8). Р 1075-1079.
  10. Brott T., Adams H. P., Olinger C. P., et al. Measurements of acute cerebral infarction - a clinical examination scale // Stroke. 1989. N 20. Р. 864-870.
  11. Broughton B. R., Reutens D. C., Sobey C. G. Apoptotic mechanisms after cerebral ischemia // Stroke. 2009. N 5. P. 331-339.
  12. Bugnicourt J. M., Leclercq C., Chillon J. M., Diouf M., Deramond H., Canaple S., Lamy C., Massy Z. A., Godefroy O. Presence of intracranial artery calcification is associated with mortality and vascular events in patients with ischemic stroke after hospital discharge: a cohort study // Stroke. 2011. N 42 (12). Р. 3447-3453.
  13. Carter A. M., Catto A. J., Mansfield M. W., Bamford J. M., Grant P. J. Predictive variables for mortality after acute ischemic stroke // Stroke. 2007. N 38 (6). Р. 1873-1880.
  14. Criddle L. M., Bonnono C., Fisher S. K. Standardizing stroke assessment using the National Institutes of Health Stroke Scale // J. Emerg. Nurs. 2003. N 6. Р. 541-546.
  15. Di Napoli M., Singh P. Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when // Stroke. 2009. N 40 (5). Р. 1549-1452.
  16. Feigin V. L., Lawes C. M., Bennett D. A. et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review // Lancet Neurol. 2009. P. 15-18.
  17. Fonarow G. C., Saver J. L., Smith E. E., Broderick J. P., Kleindorfer D. O., Sacco R. L., Pan W., Olson D. M., Hernandez A. F., Peterson E. D., Schwamm L. H. Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke // J. Am. Heart Assoc. 2012. N 1. Р. 42-50.
  18. Ghandehari K. J. Challenging comparison of stroke scales // Res. Med. Sci. 2013. N 10. Р. 906-910.
  19. Govan L., Langhorne P., Weir C. J. Categorizing stroke prognosis using different stroke scales // Stroke. 2009. N 40 (10). Р. 3396-3399.
  20. Grysiewicz R. A., Thomas K., Pandey D. K. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors // Neurol. Clin. 2008. N 26. P. 871-895.
  21. Hankey G. J. et al. Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack // Cerebrovasc. Dis. 2003. Vol. 16.
  22. Holm S., Ueland T., Dahl T. B., Michelsen A. E., Skjelland M., Russell D., Nymo S. H., Krohg-Sørensen K., Clausen O. P., Atar D., Januzzi J. L., Aukrust P., Jensen J. K., Halvorsen B. Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke // PLoS One. 2011. N 6 (12).
  23. Hsieh Y. C., Seshadri S., Chung W. T., Hsieh F. I., Hsu Y. H., Lin H. J., Tseng H. P., Lien L. M., Bai C. H., Hu C. J., Jeng J. S., Tang S. C., Chen C. I., Yu C. C., Chiou H. Y. Association between genetic variant on chromosome 12p13 and stroke survival and recurrence: a one year prospective study in Taiwan // J. Biomed. Sci. 2012. N 3. Р. 19.
  24. Jauch E. C., Lindsell C., Broderick J., Fagan S. C., Tilley B. C., Levine S. R. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study // Stroke. 2006. N 10. Р. 13.
  25. Jefferisa B., Whincupb P., Welshc P., Wannametheea G., Rumleyc A., Lennona L., Thomsona A., Lawlord D., Carsone C., Ebrahime S., Lowec G. Prospectivestudy of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women // Atherosclerosis. 2010. Vol. 208, N 2. P 557-563.
  26. Johnston S. C., Mendis S., Mathers C. D. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modeling // Lancet Neurol. 2009. P 56-59.
  27. Kang D. W., Yoo S. H., Chun S., Kwon K. Y., Kwon S. U., Koh J. Y., Kim J. S. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke // Stroke. 2009. N 40 (5). Р 1653-1658.
  28. Karlsson K. E., Wilkins J. J., Jonsson F., Zingmark P. H., Karlsson M. O., Jonsson E. N. Modeling disease progression in acute stroke using clinical assessment scales // AAPS J. 2010. N 12 (4). Р 683-691.
  29. Kitagawa K. Cerebral vessel disease and inflammatory process // Brain Nerve. 2009. N 61. P 1061-1068.
  30. Kuhlmann C. R., Librizzi L., Closhen D., Pflanzner T., Lessmann V., Pietrzik C. U., de Curtis M., Luhmann H. J. Mechanisms of C-reactive protein-induced blood-brain barrier disruption // Stroke. 2009. N 40 (4). Р 1458-1466.
  31. MacDonald B. K., Cockerell O. C., Sander J., Shorvon S. D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK // Brain. 2000. P. 665-676.
  32. Matthew B. Maas, Karen L. Furie. Molecular biomarkers in stroke diagnosis and prognosis // Biomarkers in Medicine. 2009. N 4. P 363-375.
  33. Official periodical: World Health Organization: Ten leading causes of death //Information byulleten. 2014. № 310. URL: http://www.who.int/governance/eb/who_constitution_ ru.pdf. (дата обращения: 15.04.2015)
  34. Panel M., Ed D., Robertson J., Broderick J., Duncan Р., Hershey L., Roth E., Thies H., Trombly C. The American Heart Association Stroke Outcome Classification // Stroke. 1998. N 29. P. 1274-1280.
  35. Park K. P., Rosell A., Foerch C. et al. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats // Stroke.2009. N 40 (8). P. 2836-2342.
  36. Purroy F., Montaner J., Molina C. A., Delgado P., Arenillas J. F., Chacon P., Quintana M., Alvarez-Sabin J. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. C-reactive protein predicts further ischemic events in transient ischemic attack patients // Acta Neurol. Scand. 2007. N 115 (1). Р 60-61.
  37. Ribo M., Montaner J., Molina C. A., Arenillas J. F., Santamarina E., Alvarez-Sabín J. Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator // J. Thromb Haemost. 2004. N 91 (6). Р 1146-1151.
  38. Rosell A., Alvarez-Sabín J., Arenillas J. F., Rovira A., Delgado P., Fernández-Cadenas I., Penalba A., Molina C. A., Montaner J. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke // J. Stroke. 2005. N 36. P 1415-1420.
  39. Rosell A., Ortega-Aznar A., Alvarez-Sabín J., Fernández-Cadenas I., Ribó M., Molina C. A., Lo E. H., Montaner J. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke // Stroke. 2006. N 37 (6). Р 1399-1406.
  40. Smith C. J., Emsley H. C., Gavin C. M., Georgiou R. F., Vail A., Barberan E. M., del Zoppo G. J., Hallenbeck J. M., Rothwell N. J., Hopkins S. J., Tyrrell P. J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome // Neurol. 2004. N 15. Р 2.
  41. Sotgiu S., Barone R., Zanda B., Arru G., Fois M.L., Arru A., Rosati G., Marchetti B., Musumeci S. Chitotriosidase in patients with acute ischemic stroke // Eur. Neurol. 2005. N 54 (3). Р. 53.
  42. Sotgiu S., Zanda B., Marchetti B., Fois M. L., Arru G., Pes G. M., Salaris F. S., Arru A., Pirisi A., Rosati G. Inflammatory biomarkers in blood of patients with acute brain ischemia // Eur. J. Neurol. 2006. N 13 (5). Р 505-513.
  43. Van Seeters T., Biessels G. J., van der Schaaf I. C., Dankbaar J. W., Horsch A. D., Luitse M. J., Niesten J. M., Mali W. P., Kappelle L. J., van der Graaf Y., Velthuis B. K. Prediction of outcome in patients with suspected acute ischaemic stroke with CT perfusion and CT angiography: the Dutch acute stroke trial (DUST) study protocol // BMC Neurol. 2014. N 25. Р 14-37.
  44. Weimar C. 1., König I. R., Kraywinkel K., Ziegler A., Diener H. C. Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models // German Stroke Study Collaboration. Stroke. 2004. N 35 (1). Р 158-162.
  45. Weiss A., Beloosesky Y., Kenett R. S., Grossman E. Systolic blood pressure during acute stroke is associated with functional status and long-term mortality in the elderly // Stroke. 2013. N 44 (9). Р 2434-1440.
  46. Welsh P., Barber M., Langhorne P., Rumley A., Lowe G. D., Stott D. J. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke // Cerebrovasc. Dis. 2009. N 27 (3). Р 247-253.
  47. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., Wardlaw J., Dennis M., Sudlow C. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6 // PLoS Med. 2009. N 6 (9). Р e1000145.
  48. Williams D. R. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau // Intern. Med. J. 2006. N 36 (10). Р 652-660.
  49. Wunderlich M. T., Lins H., Skalej M., Wallesch C. W., Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke // Clin. Neurol. Neurosurg. 2006. N 6. Р 63.
  50. Yamamoto L., Magalong E. Outcome measures in stroke // Crit. Care Nurs. Q. 2003. N 4. Р 283-293.

Copyright (c) 2015 Human Ecology


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies